Octapharma
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Octapharma
RECRUITINGNCT03695978
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A...
International, post-authorisation non-interventional study to evaluate real-life effectiveness, safety and utilisation patterns of Octapharma's FVIII concentrates Nuwiq, Octanate,...
Sponsor: OctapharmaEnrolling: 20020 locations
Haemophilia A
RECRUITINGPhase 4NCT05935358
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Recombinant factor VIII for the prevention of bleeding in patients with severe haemophilia A undergoing major surgery while receiving emicizumab prophylaxis
Sponsor: OctapharmaEnrolling: 2818 locations
Severe Hemophilia A
RECRUITINGPhase 4NCT05936580
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Recombinant factor VIII for the prevention of bleeding in women/girls with haemophilia A undergoing major surgery
Sponsor: OctapharmaEnrolling: 2815 locations
Hemophilia A